Skip to main content
. 2020 Jul 1;35(3):226–228. doi: 10.4103/ijnm.IJNM_58_20

Figure 2.

Figure 2

Whole-body posttherapy actinium-225 tetraazacy clododecanetetraacetic acid–octreotide anterior (a) and posterior (b) images showing intense accumulation in pararectal lesion and liver metastases (arrows) (note there is no bladder activity)